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Abstract
Mast cells are important sentinels guarding the interface between the environment and the body: a
breach in the integrity of this interface can lead to the release of a plethora of mediators which
engage the foreign agent, recruit leukocytes, and initiate adaptive physiological changes in the
organism. While these capabilities make mast cells critical players in immune defense, it also
makes them important contributors to the pathogenesis of diseases such as asthma. Mast cell
mediators induce dramatic changes in smooth muscle physiology, and the expression of receptors
for these factors by smooth muscle suggests that they act directly to initiate constriction. Contrary
to this view, we show here that mast cell-mediated bronchoconstriction is observed only in
animals with intact innervation of the lung and that serotonin release alone is required for this
action. While ablation of sensory neurons does not limit bronchoconstriction, constriction after
antigen challenge is absent in mice in which the cholinergic pathways are compromised. Linking
mast cell function to the cholinergic system likely provides an important means of modulating the
function of these resident immune cells to physiology of the lung, but may also provide a
safeguard against life-threatening anaphylaxis during mast cell degranulation.
Keywords
Rodent; Mast Cells; Allergy; Lung
Introduction
IgE-dependent mast cell activation is the central mechanism underlying immediate allergic
reaction (1). Cross-linking of IgE bound by Fc receptors on mast cells leads to release of
preformed mediators stored in the mast cell granules, as well as production of lipid
mediators and up-regulation of cytokine synthesis (1). These mediators can profoundly
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influence the physiology of the organism and thus systemic release of mast cell mediators
can result in life threatening anaphylaxis. Mast cells can also contribute to chronic
inflammatory diseases, including asthma, where activation by environmental allergens
contributes to inflammation and reversible airway constriction, a hallmark of this disease.
Consistent with a role for mast cells in this aspect of asthma, an increase in airway mast
cells has been reported in asthmatic patients compared to healthy individuals (2).
The mechanism(s) through which mast cell mediators contribute to the airway obstruction is
not yet completely understood. However, airway smooth muscle (ASM) expresses many
receptors for mediators produced by mast cells (3). Thus, in the simplest model, mast cell
mediators, including cysteinyl leukotrienes (cysLTs), histamine and serotonin (5-HT) act
directly on smooth muscle, triggering increases in intracellular Ca2+ followed by assembly
of the contractile apparatus. Direct ability of several mast cell mediators to elicit Ca2+ flux
in muscle cells and constriction of tracheal rings further supports this model (4–6).
In a number of organ systems, close interaction of mast cells with both sensory and
parasympathetic neurons has been demonstrated, suggesting that mast cells may induce
bronchoconstriction by altering the activity of the neuronal pathways which function to
determine ASM tone. For example, histamine released by mast cells is reported to stimulate
parasympathetic neurons in the guinea pig heart (7), while antigen challenge in sensitized
rats results in the activation of afferent nerve fibers in the gut mediated by both histamine
and serotonin (8). Consistent with this, mucosal mast cell mediators from patients with
irritable bowl syndrome were reported to excite rat nociceptive visceral sensory nerves (9).
Additionally, a number of studies suggest that this relationship is also present in other
organs including the lung. For example it has been reported that substance P containing
nerves in the rat trachea interact with mast cells to cause antigen-specific, and dependent,
changes in lung solute clearance and epithelial chloride ion secretion (10–12).
In humans, the cholinergic parasympathetic nervous system represents the predominate
bronchoconstrictor pathway in the airways. Efferent cholinergic nerve fibers run through the
vagus nerve and synapse in small ganglia within the airway wall. These nerve fibers release
acetylcholine (ACh), which binds nicotinic acetylcholine receptors (nAChRs) on the
parasympathetic ganglion, which activates postganglionic fibers innervating ASM and
submucosal glands. These postganglionic fibers release ACh, which binds to muscarinic
acetylcholine receptors (mAChRs) directly on ASM. The activity of the parasympathetic
pathway is modulated by sensory neurons present throughout the airway. Supporting a role
for the mast cell interaction with the autonomic nervous system, mast cells have been shown
to be closely associated with airway nerves (13), and receptors for many mast cells
mediators, including histamine and serotonin, are expressed by neurons (14–16). In the
studies detailed here we demonstrate that in allergic mice, antigen challenge induces
constriction of the central airways, and this constriction is dependant not only on mast cells
but also on an intact parasympathetic system.
Materials and methods
Experimental animals
All studies were conducted in accordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals and were approved by the Institutional Animal
Care and Use Committee (IACUC) guidelines of the University of North Carolina at Chapel
Hill. Mast cell deficient C57BL/6KitW-sh/KitW-sh, PAR2−/− (17) and their wild-type C57BL/
6J controls were purchased from Jackson Laboratory. M1 and M3 mAChR-deficient mice
and their controls were bred as previously described (18, 19). The generation of congenic
5HTT-deficient mice has been previously described (20). All experiments were carried out
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using 8–12 week old mice, with the exception of the 5-HTT mice. Both control and
experimental animals were 6 months of age.
Airway measurements in intubated mice
Mechanical ventilation and airway measurements were carried out as previously described
(21). After baseline measurements, serotonin (6.25 µg/ml, Sigma Chemical) was
administered i.v. through a jugular catheter in increasing doses (0.3, 0.6, and 1.2 pg/ml).
Single doses of DNP (250 µl, 5 mg/ml, Sigma Chemical) or OVA (50 µl, 10 mg/ml, Grade
V, Sigma Chemical) were also delivered i.v. through a jugular catheter. After administration,
airway mechanics were determined using the Forced Oscillatory Technique (FOT) every 10
s for 3 min. The resultant pressure and flow data were fit to a constant phase model as
previously described (22). Similar to other studies assessing FOT, we confined our analysis
to Raw (Rn; Newtonian resistance), which assesses the flow resistance of the conducting
airways, and G (tissue damping), which reflects tissue resistance in the peripheral airways
(23). Total lung resistance (RL) was calculated from the FOT data by adding tissue
resistance (Rti) to Raw as previously described (23, 24). Where Rti is given by:
where f is the frequency in Hz and α = (2/π) tan−1(H/G). All data are represented as percent
baseline RL, Raw or G.
To determine the contribution of various receptors in airway responses, mice received a pre-
treatment i.p. injection of pharmacological antagonist before exogenous administration of
mediators or antigen. To asses the role of mAChRs and nAChRs to airway responses, mice
received a pre-treatment i.p. injection of atropine sulfate (10µM/kg, American
Pharmaceutical Partners) or mecamylamine (4mg/kg, Sigma Chemical), respectively.
Methiothepin (2mg/kg, i.p.), ketanserin (12 mg/kg, i.p.), and ondansetron (1 mg/kg, i.p.)
were administered to block serotonin receptors. Methiothepin is a nonspecific antagonist,
whereas ketanserin and ondansetron are specific antagonists for 5-HT2A and 5-HT3
receptors, respectively.
Anaphylaxis protocols
IgE-dependent passive anaphylaxis—Mice were sensitized with 20 µg mouse
monoclonal anti-DNP IgE (1.0 mg/ml, Sigma Chemical; 200 µl total volume in saline) or an
equal volume PBS i.v. through the tail vein. Approximately 19–24 hours after anti-DNP IgE
injection, mice were anesthetized, catheterized, tracheostomized and mechanically ventilated
as described above. Immediately following the baseline measurements, 0.25 ml of 5 mg/ml
DNP (or an equal volume of PBS) was injected into the jugular and airway parameters were
measured every 10 s for 3 min immediately following anaphylaxis induction. Bar graphs
represent the area under the curve.
Active systemic anaphylaxis to OVA—Mice received a single i.p. injection of 0.2 ml
sterile 0.9% NaCl containing 20 µg OVA emulsified in 2.25 mg aluminum hydroxide gel
(Sigma Chemical). 18–21 days after OVA immunization, mice were anesthetized, placed on
a ventilator, challenged with a single i.v. infusion (via a jugular catheter) of 500 µg of OVA
in 50 µl of sterile 0.9% NaCl and airway measurements were taken every 10 s for 3 min
(25). Control mice were challenged with an equal volume of sterile 0.9% NaCl. Bar graphs
represent the area under the curve.
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Acute anaphylaxis to OVA following induction of allergic airway disease—
Mice were sensitized by i.p. injection of 20 µg OVA emulsified in 2.25 mg aluminum
hydroxide gel in a total volume of 200 µl on days 1 and 14. Mice were challenged (45 min)
via the airways with OVA (1% in saline) for 5 days (days 21 – 25) using an ultrasonic
nebulizer (DeVillbiss Health Care, Somerset, PA). On day 26 mice were anesthetized,
placed on a ventilator, challenged with a single iv infusion (via a jugular catheter) of 500 µg
of OVA in 50 µl of sterile 0.9 % NaCl. Airway measurements were taken every 10 s for 3
min. Bar graphs represent the area under the curve.
After airway measurements, mice were sacrificed and 0.5–1.0 ml of blood was collected by
cardiac puncture. Following coagulation, serum was collected. Total IgE levels in the serum
were measured by ELISA (R&D systems). BAL was performed successively with 1.0 ml of
sterile HBSS five times. The recovered BAL fluid was centrifuged to remove cells.
Histamine levels were measured in the cell-free supernatant by ELISA (Beckman Coulter).
Inhibition of serotonin with 4-Chloro-DL-phenylalanine (PCPA)
Mice received a single i.p. injection of 0.2 ml sterile 0.9% NaCl containing 20 µg OVA
emulsified in 2.25 mg aluminum hydroxide gel. 18–21 days after OVA immunization, mice
were treated with PCPA (150 mg/kg, i.p.; 25 mg/ml in 1N HCl) and immediately challenged
with 250 µg of OVA in 50 µl of sterile 0.9% NaCl (i.v.) to deplete serotonin stored in mast
cells. 24 hours later, mice received a second treatment of PCPA (150 mg/kg, i.p.) and were
then anesthetized, placed on a ventilator, and challenged with a single i.v. infusion (via a
jugular catheter) of 500 µg of OVA in 50 µl of sterile 0.9% NaCl and airway measurements
taken every 10 s for 3 min. Control mice were challenged with an equal volume of sterile
0.9% NaCl.
After airway measurements, mice were sacrificed and 0.5–1.0 ml of blood collected by
cardiac puncture with a syringe containing 20 µl 100 U/ml heparin. The blood was then
centrifuged at 12000 rpm for 5 min to collect plasma. Serotonin levels were measured in the
plasma by ELISA (Beckman Coulter).
Sensory ablation
Adults—Capsaicin was administered to ablate sensory neurons as previously described (26,
27). For pretreatment, mice received a s.c. dose of 25 mg/kg capsaicin at 0 hrs and a second
s.c. dose of 75mg/kg capsaicin at 24 hrs (5 and 15 mg/ml capsaicin dissolved in 1:1:8
ethanol:Tween80:saline, respectively). To minimize the respiratory effects associated with
capsaicin injection, animals were first anesthetized with avertin (250 mg/kg, i.p.) and then
treated with 10 mg/kg theophylline (s.c., 5 mg/ml in distilled water, Sigma Chemical) and
0.1 mg/kg terbutaline (i.p., 0.05 mg/ml in saline, Sigma Chemical). Airway assessment was
conducted 10–12 days after the final capsaicin treatment.
Neonates—Pups were injected with 50 mg/kg capsaicin (15 mg/ml, s.c.) at day 2 to 3 after
birth to degrade sensory neurons. Animals were aged to 8 weeks of age before conducting
studies.
To check for effectiveness of the treatment, a drop of 0.1 mg/ml capsaicin was instilled into
one eye of each mouse and wiping movements were counted as previously described (28,
29). For substance P measurements, lungs were lavaged with 0.4 ml chilled PBS containing
500 KIU/ml aprotinin (Sigma Chemical). Substance P was measured from BAL by ELISA
(R&D systems).
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A surgical vagotomy was conducted to assess the contribution of intact parasympathetic
innervation as previously described (30). Briefly, the right and left vagus nerves running
parallel to the trachea were isolated and a piece of surgical string was passed underneath to
facilitate cutting during mechanical ventilation. In experimental animals, basal lung
mechanics were established before severing of both vagus nerves. Post vagotomy baseline
was then reassessed prior to i.v. challenge. Control animals received a sham operation which
involved simply lifting and releasing of the surgical string along with the nerve fibers.
Statistical analysis
Data are represented as means ± SEM. Analysis Of Variance (ANOVA) followed by Tukey-
Kramer Honestly Significant Difference for multiple comparisons was performed on
complex data sets. Statistical significance for single data points was assessed by Student’s
two-tailed t-test. A P value of <0.05 was considered statistically significant.
Results
Change in airway resistance during anaphylaxis is dependant on mast cells, primarily
those located in the central airways
We first determined the contribution of mast cells to changes in airway mechanics. Previous
studies have shown that in the mouse, antigen treatment following sensitization results in
rapid decrease in lung conductance (GL) (25), which is the inverse of lung resistance (RL).
Similarly, we found that sensitization of wild-type C57BL/6 (B6) mice with OVA plus
adjuvant, followed by exposure to antigen, resulted in a rapid and dramatic increase in RL
(Figure 1 A). Similar immunization and challenge of C57BL/6 KitW-sh/KitW-sh (Wsh/Wsh)
mice, which lack mast cells, failed to induce changes in lung mechanics, indicating that this
response was dependent on the normal development of this cell population (Figure 1 B). To
verify that the difference in RL was not due to a reduction in overall IgE production in the
mast cell deficient animals, we compared total serum IgE levels in the B6 and Wsh/Wsh
congenic pairs (Figure 1 C). There was no difference in IgE production between the two
groups.
Mast cells are located throughout the airways including the trachea, bronchus, and
sporadically in the parenchyma (31), yet it is unclear whether all of these cells contribute to
changes in lung physiology during anaphylaxis. To examine this point more closely, we
monitored changes in airway mechanics after sensitization and exposure to OVA using FOT.
Interestingly, using this method we found that the changes in lung mechanics were largely
limited to a parameter termed ‘airway resistance’ or Raw, which a number of theoretical and
experimental studies suggest is sensitive primarily to changes in the central airways (32). As
can be seen in figure 1 D, antigen induced a significant and robust change in Raw in B6 mice
previously sensitized to OVA plus adjuvant and little to no change in G, a parameter termed
‘tissue damping’ that is associated with changes in the distal lung. In contrast, no change in
Raw was observed in mast cell deficient Wsh/Wsh mice after antigen challenge or in mice
treated with vehicle (Figure 1 E). To further verify these findings, we examined changes in
airway mechanics in a mouse model of passive anaphylaxis. Mice received i.v. monoclonal
anti-DNP IgE, and 24 hours later, after establishment of baseline lung mechanics, mast cell
degranulation was induced by i.v. delivery of antigen (DNP). DNP induced similar increases
in Raw as those seen during active anaphylaxis to OVA (data not shown). Unlike antigen
induced constriction, airway constriction induced with methacholine (MCh), a stable
acetylcholine analog, resulted in both changes in Raw and G consistent with both changes in
the central and distal airways in response to this neurotransmitter (Figure 1 F). Similar
responses to both antigen and MCh challenge were also observed in the BALB/c and 129/
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SvEv strains (data not shown). This suggests that although the ability of methacholine to
induce airflow obstruction is distributed throughout the lung, mast cell degranulation results
in only central airway constriction, despite the presence of these cells in peripheral airways.
We next asked whether this is also the case in mice with inflamed airways, particularly in
those with allergic lung disease. To address this question we induced allergic lung disease in
B6 and Wsh/Wsh mice by sensitization and challenge with OVA using an immunization
protocol previously shown to induce similar levels of inflammation in both lines (33). As
expected, the absence of mast cells in the Wsh/Wsh mice did not significantly alter any of
the disease parameters including IgE production, cellularity of the BAL fluid, mucus cell
hyperplasia or the induction of the Th2 pathway (Supplemantal Figure S1). Twenty-four
hours after the last OVA challenge, changes in airway resistance in response to antigen were
measured using FOT, monitoring both Raw and G changes in lung mechanics in the OVA
treated mice. Despite robust inflammation in the central and distal lung, changes in airway
mechanics were limited to parameters associated with the central airways. A significant
increase in Raw was observed; however, no significant increase in G was observed after
infusion of antigen into mice with inflamed lungs (Figure 2 A). Similar to actively sensitized
animals, the increase in Raw after OVA challenge in mice with allergic airway disease was
dependent on mast cells; Wsh/Wsh mice failed to respond to antigen challenge Figure 2 B).
As would be expected given the absence of mast cells in the Wsh/Wsh mice, no histamine
was detected in the Wsh/Wsh animals, while this mediator could easily be detected in the
BAL from B6 mice following antigen challenge Figure 2 C). Similar to the naïve airway,
antigen induced constriction appears to be located within the central airways.
Mast cell release of serotonin alone mediates airway constriction during anaphylaxis
To address the contribution of the various mast cell mediators to allergen-induced
bronchoconstriction we took advantage of a number of pharmacological and genetic tools to
examine the impact of loss of various pathways on the changes in Raw during anaphylaxis
(Supplemental Methods; Figure S2). Anaphylaxis results in a measurable increase of
leukotriene (LT) C4 in the BAL (34). To examine the contribution of LTC4 to anaphylactic
bronchoconstriction, we utilized animals lacking the enzyme 5-lipoxygenase (5LO), which
is required for the synthesis of all leukotrienes. The inability of the mast cells to produce this
lipid mediator did not alter bronchoconstriction after induction of passive anaphylaxis in
5LO−/− mice (Figure S2 C). Although prostaglandin (PG) D2 has been shown to be
synthesized and released during IgE-dependent activation of mouse bone marrow-derived
mast cells (35), no attenuation of airway resistance was noted in mice in which the
production of prostaglandins was inhibited by treatment with the NSAID indomethacin
(Figure S2 B). Similarly, antagonists which block the H1 and H2 histamine receptors did not
significantly alter anaphylactic bronchoconstriction (Figure S2 A). The most abundant
mediator found in human mucosal mast cells, tryptase, has the ability to activate protease
activated receptor 2 (PAR2) receptors, which can mediate airway constriction under some
experimental conditions (36). To determine whether this pathway was involved in
bronchoconstriction associated with anaphylaxis, we examined this response in PAR2−/−
mice (17); no difference in Raw was noted between the mutant and control animals (Figure
S2 D).
Mast cells express the enzyme required for the production of serotonin (37), and previous
studies have indicated that serotonin can mediate changes in lung resistance (38). We
therefore first asked whether the change in airway mechanics mediated by serotonin were
also limited to the central airways. As can be seen in figure 3 A, exogenous serotonin
induced a dose-dependent increase in Raw with little change in G: a pattern that is similarly
observed after mast cell degranulation. To address the role of serotonin in mast cell
mediated bronchoconstriction more directly, we examined the impact of PCPA on airway
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resistance. PCPA inhibits the activity of tryptophan hydroxylase, an enzyme which carries
out the essential step in the synthesis of serotonin. Mice were sensitized with OVA and three
weeks later treated with either vehicle or PCPA prior to the induction of anaphylaxis by
injection of antigen. Antigen exposure resulted in a robust increase in airway resistance in
the vehicle treated animals. In contrast, airway resistance was abolished in mice treated with
PCPA, despite the normal degranulation of mast cells in these animals; histamine levels in
the BAL collected immediately after induction of anaphylaxis were not significantly
different between the two groups (Figure 3 B). Furthermore, no difference was observed
between the PCPA and control animals in the ability of their airways to respond to MCh
(Figure 3 C). As expected, anaphylaxis resulted in a measurable increase in plasma serotonin
levels, but this increase was not observed in the PCPA treated mice (Figure 3 D). Thus, the
protection of the PCPA treated mice from bronchoconstriction was due to attenuated
serotonin release and not to alterations in either smooth muscle function or the
responsiveness of mast cells to antigen.
To rule out a possible role for platelet-derived serotonin in this model, we examined the
response to IgE and antigen in mice lacking the serotonin transporter. While mast cells
express tryptophan hydroxylase and thus can produce serotonin, platelets acquire this
mediator via the serotonin transporter as they pass through the intestinal circulation. Thus
platelets from mice and rats lacking the transporter also lack serotonin (39, 40). 5HTT-
deficient mice demonstrate wild-type levels of constriction after antigen challenge (Figure 3
E) indicating that platelet-derived serotonin is not critical for this response. Serotonin-
dependent constriction was also observed in BALB/c mice (Supplemental Figure S3), which
are commonly thought of as prototypical Th2 responders.
If bronchoconstriction is mediated by mast cell-derived serotonin, it would follow that
agents that block serotonin receptors would also attenuate changes in Raw. Serotonin-
induced increases in Raw were abolished by both the non-specific antagonist methiothepin
and the 5-HT2A-specific antagonist ketanserin, whereas the 5-HT3-specific antagonist
ondansetron failed to attenuate this increase in airway mechanics (data not shown). Both
methiothepin and ketanserin abolished allergic airway constriction in passively sensitized
mice (Figure 3 F). Together these studies indicate that while mast cells release many
mediators that may modulate the inflammatory response, serotonin alone mediates the
changes in airway resistance during anaphylaxis through its action on 5-HT2A receptors.
Intact sensory innervation is not required for mast cell mediated bronchoconstriction
Our observation that the ability of mast cells to mediate bronchoconstriction was sensitive to
the location of these cells in the lung, and our observation that serotonin alone mediated this
response, suggested to us that the mast cell-mediated constriction may result from indirect
stimulation of sensory neurons, triggering a bronchial reflex. To test this hypothesis we
examined the ability of IgE and antigen to induce constriction in mice in which sensory
neurons had been ablated by treatment with capsaicin. Ablation of sensory C-fibers with
capsaicin in both adults and neonates failed to significantly decrease Raw after antigen
challenge in passively sensitized mice (Figure 4 A–B), suggesting that capsaicin-sensitive
C-fibers do not play a primary role in allergic airway constriction. Substance P, the primary
neurotransmitter stored in C-fibers, was measured to evaluate the efficacy of capsaicin
treatment. Antigen challenge in passively sensitized mice increased substance P levels in the
BAL, but was attenuated in mice pretreated with capsaicin (Figure 4 C), verifying that the
capsaicin treatment ablated substance P containing C-fibers in these animals.
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Vagotomy abolishes anaphylactic airway constriction in both the naïve and allergic airway
The tone of ASM is largely dependent on parasympathetic innervation, which travels in the
vagus nerve. Mast cells have been observed close to the vagus nerve and parasympathetic
ganglia in other organisms and tissues (7, 13, 41), raising the possibility of cooperation
between mast cells and these cholinergic fibers in bronchoconstriction. To test this
hypothesis, we examined mast cell-mediated bronchoconstriction in mice in which the
cholinergic pathways were disabled using a number of approaches.
Blockade of nAChRs with the nonspecific nicotinic antagonist mecamylamine, prior to
antigen challenge, abolished antigen-induced increases in Raw in passively sensitized mice
(Figure 5 A). Post-ganglionic fibers release ACh which binds mAChRs expressed by smooth
muscle cells to initiate contraction. Blockade of mAChRs with the nonspecific muscarinic
antagonist atropine resulted in complete absence of airway constriction after antigen
challenge in both B6 (Figure 5 B) and BALB/c mice (Supplemental Figure S4). To further
define the muscarinic receptors required for mast cell mediated bronchoconstriction, we
examined a series of mouse lines deficient in M1 or M3 mAChRs. Complete attenuation of
Raw was only observed in the mice lacking the M3 mAChR (Figure 5 C), which has been
shown to be expressed by airway smooth muscle (3).
The observation that disruption of both nicotinic and muscarinic neuronal transmission
inhibits anaphylactic changes in airway mechanics suggests that an intact parasympathetic
pathway is required for this mast cell function. If this is the case, we would expect that
severing the incoming neural fibers would eliminate IgE/antigen mediated
bronchoconstriction. To test this hypothesis, mice were treated with either IgE or saline and
the following day the vagus nerve was severed prior to treatment with antigen. Control
groups in which the nerve was isolated but not severed were also prepared. Vagotomy
abolished antigen-mediated airway constriction in both B6 (Figure 6 A) and BALB/c mice
(Supplemental Figure S4). We next determined whether severing the vagus nerve altered the
ability or extent of mast cell degranulation in the airways by measuring histamine levels in
the BAL immediately after measurement of airway parameters. No difference in histamine
levels was seen following vagotomy (Figure 6 B). To verify that the vagotomy did not alter
fundamental properties of the ASM, we confirmed that this surgical procedure did not alter
the response of the mice to MCh (Supplemental Figure S5).
Inflammation results in the recruitment of cells to the lung. This raises the possibility that, in
such an environment, mast cells may bring about changes in airway caliber in response to
antigen independent of parasympathetic pathways. To test this, we induced allergic lung
disease in mice and examined the impact of vagotomy on these animals. Again, vagotomy
abolished increases in Raw following antigen challenge (Figure 6 C).
If serotonin released by mast cells collaborates with signals derived from the
parasympathetic pathways, one would expect that constriction of the airways to exogenous
serotonin to show similar sensitivity to changes in the activity of this system. Supporting the
role of serotonin in neural mediated anaphylaxis, administration of exogenous serotonin
exhibited dose dependent central airway constriction that was sensitive to both vagotomy
and atropine (Figure 6 D). Additionally, pretreatment with a non-provoking dose of
serotonin resulted in an additive effect on bronchoconstriction to a non-provoking dose of
MCh (Figure 7). Together these studies support a model in which mast cell derived
serotonin collaborates with cholinergic pathways of the lung to bring about changes in
airway patency during anaphylaxis.
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We show here that IgE-mediated degranulation of mast cells leads to an increase in the
release of mast cell specific mediators in the mouse lung accompanied by changes in airway
mechanics. These changes in airway mechanics are dependent on both mast cell release of
serotonin and intact cholinergic innervation of the lung. Similar to previous studies (42) we
show that there was a dramatic increase in total RL following antigen challenge, similar in
magnitude to that generally achieved with 2 µg i.v. MCh (data not shown). More recently it
has become possible to evaluate changes in airway mechanics using FOT. Using the input
impedance of prime waves of various amplitudes, fit to the constant phase model of the
lung, airflow obstruction following anaphylaxis can be distinguished between the central
and peripheral airways (23, 32). Using this method we found that while MCh affects
parameters associated with changes in mechanics of both the central and peripheral airways,
changes observed after mast cell degranulation were surprisingly limited to the central
airways despite the fact that these cells can be found throughout the lung, including within
the distal airways and lung parenchyma (31). A number of different explanations are
possible for this observation. First while mast cells are found throughout the lung in B6
mice, a larger concentration are localized within close proximity of bronchial smooth muscle
while few are found in the alveolar spaces and within the lung parenchyma (31). While
antigen exposure may lead to degranulation of cells in the distal lung, the distribution of the
receptor(s) sensitive to mast cell mediators may also be biased towards smooth muscle of
the central airways. Alternate explanations are also possible. For example, it is possible that
cholinergic innervation is more abundant in the central airways, or that the mast cell
localization in respect to these neurons differs at different levels of the airways. However,
our observation that inhaled serotonin leads to changes in lung mechanics similar to that
observed upon mast cell degranulation suggests that the distribution of serotonin receptors
plays a role in limiting the response to the larger airways. This finding differs from studies
carried out on precision cut lung slices prepared from rats in which constriction of airways
was observed in both the distal and proximal airways (43). In this study antigen challenge of
passively sensitized lung slices resulted in both stronger and faster constriction of the small
airways when compared to the large conducting airways. Similarly, serotonin-provoked
responses were also greater in the peripheral airways. In addition, passively sensitized lung
slices from humans have also been reported to have an increased response to antigen with
decreasing airway size (44). The difference in these findings underscores the continuing
importance of verification of ex vivo findings in an animal model. Alternately, this may
reflect differences between species in the anatomical distribution of mast cells, ASM, airway
receptors, or a combination thereof; and may also indicate that while bronchoconstriction in
mice is restricted to central airways this may not be representative of all species.
Mast cells produce a number of mediators that have been shown, both in vitro and in vivo, to
mediate airway constriction, including LTC4/LTD4, PGD2, tryptase and histamine. Direct
testing using mice lacking 5LO indicated that leukotrienes are not required for IgE/antigen
mediated airway constriction, at least in this species. Likewise, inhibition of endogenous
prostaglandin production using the NSAID indomethacin failed to inhibit antigen-induced
increases in Raw, ruling out the involvement of PGD2 in this response. Furthermore, mice
lacking PAR2 responded similarly to wild-type animals, indicating that, in the mouse,
activation of PAR2 receptors by tryptase is not essential for airway constriction in this
model. Nor did we find evidence supporting a role for mast cell derived histamine in this
response, despite the ability of inhaled histamine to induce an increase in airway resistance
in humans (45) and to modestly increase Raw in some mouse strains (data not shown). In
contrast, both inhibition of serotonin synthesis and blockage of the serotonin 5-HT2A
receptor completely abolished the change in airway mechanics after antigen challenge. This
finding is consistent with a number of previous studies using mice, in which
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pharmacological agents were shown to attenuate changes in airway mechanics. For example,
Eum et al. reported that pretreatment of antigen challenged mice with the non-specific
serotonin receptor antagonist methysergide significantly attenuated anaphylactic
bronchoconstriction (42). 5-HT2 receptor specific antagonists have also been shown to
attenuate serotonin-induced increases in pulmonary mechanics (46).
Serotonin has been reported to activate human airway smooth muscle ex vivo (47). However,
unlike LTC4 and histamine, serotonin inhalation does not lead to increased airway
constriction, even in asthmatics (48). Furthermore, until recently, it was believed that human
mast cells, unlike the rodent counterpart, could not produce serotonin. Careful study of these
cells has revealed both the expression of tryptophan hydroxylase and the localization of
serotonin (37); however, these findings are limited to cells derived ex vivo and levels were
quite small relative to the amounts stored in rodent mast cell granules. Despite the differing
expression between human and mouse mast cells, a re-evaluation of potential roles for this
pathway in human mast cells is warranted. For example it is possible that localized release
of this mediator in close apposition to nerves or ASM can produce a significant change in
the activity of the parasympathetic pathway, and that this activity is not easily mimicked by
delivery to the epithelial surface.
The vagus nerve contains both the incoming parasympathetic efferents and the sensory
nerves originating from the lung, and thus the loss of response in mice after vagotomy is
consistent with a model in which mast cells release mediators that stimulate sensory
neurons. Sensory neuron activation can lead to both local release of mediators and a
bronchial reflex resulting in increased activity of the parasympathetic pathway, a response
lost in the vagotomized mice. The serotonin 5-HT3 receptor is known to be involved in
activation and depolarization of sensory neurons in several species including the mouse (15).
It is possible that serotonin released by mast cells activates sensory neurons to elicit a
bronchial reflex. Past studies in various species have suggested the involvement of sensory
neurons in the allergic response. For example, degranulation of purified human lung mast
cells enhanced the excitability of rabbit visceral sensory C-fibers in vitro (49). Furthermore,
antigenic stimulation of sensitized guinea pig bronchi caused increased sensitivity of sensory
nerve endings (50). Consistent with this, Yu et al. showed that mast cell degranulation
enhanced the excitability of guinea pig esophageal C-fibers to mechanical and chemical
stimulation (51). In the rat, capsaicin-sensitive neurons interact with mast-cells to influence
lung solute clearance and chloride ion secretion in the trachea (10–12). Our observation does
not support this mechanism, as pretreatment of the mice with capsaicin had little impact on
mast cell mediated airway constriction while, as expected, release of substance P by these
neurons was all but eliminated. Consistent with this, pretreatment of mice with the 5-HT3
receptor specific antagonist ondansetron did not attenuate serotonin-induced increases in
airway mechanics (data not shown). While it is unlikely that substance P is involved in this
reaction, as animals were treated both as adults and as neonates, the involvement of this
neurotransmitter cannot be completely discounted as effects of specific NK receptor
antagonists were not evaluated.
A number of lines of evidence presented here support a critical role for parasympathetic
neurons in mast mediated bronchoconstriction. This includes the loss of the antigen-induced
contractile response in vagotomized mice, the ability of antagonists of both nAChRs and
mAChRs to block the response, and the inability of IgE and antigen to trigger
bronchoconstriction in mice lacking the M3 receptor. In recent years, studies have suggested
that the cholinergic contractile response to serotonin depends on a non-neuronal source of
ACh, specifically, serotonin released from the epithelium (46). This hypothesis was based
largely on in vitro studies of mouse isolated trachea challenged with exogenous serotonin.
They showed that serotonin induced contractions of tracheal smooth muscle was sensitive to
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epithelial removal but not to inhibition of neural pathways, and that these contractions were
dependent on the release of ACh. Our studies do not support this hypothesis, as it would
predict that severing the vagus nerve would have no effect on the ability of serotonin to
induce bronchoconstriction. Our data show that in vivo, airway constriction from both
exogenous serotonin and mast cell-derived serotonin is sensitive to vagotomy.
A number of models for mast cell interaction with the cholinergic neural pathway are
possible. First it is possible that mast cells increase transmission at the preganglionic
terminal, either by increasing ACh release or augmenting the activity of nAChRs. Second,
mast cell mediators could amplify the release of ACh from postganglionic nerve terminals.
Finally, activation of serotonin receptors on ASM may lead to smooth muscle contraction
only when ACh, which is released at low levels constitutively by the parasympathetic fibers,
occupies M3 receptors present on ASM. A number of studies support the models in which
antigen challenge induces an increase in release of ACh.Ex vivo studies have measured an
increase in ACh levels after stimulation with antigen in both mouse and canine tracheal
rings (52, 53). Drugs which decrease ACh metabolism increased bronchoconstriction after
either antigen or 5-HT challenge (42). However, our finding that only the 5-HT2A receptor
antagonist attenuates this response, coupled with evidence that supports the localization of
this receptor to ASM (54) and not cholinergic fibers, supports the later model in which the
impact of engagement of the 5-HT2A receptors is dependent on M3 receptors present on
ASM. The need for this “second signal” is not clear. Serotonin alone can shorten smooth
muscle in vitro and in ex vivo lung slices (54, 55), and therefore the observation that in the
mouse its ability to alter smooth muscle activity in vivo is regulated by parasympathetic
pathways is somewhat surprising. However, it is interesting to speculate that this
relationship represents one of a number of “checks and balances” designed to safeguard the
patency of the airways, limiting the activity of smooth muscle modulators stored by mast
cells, while at the same time allowing mast cells to safeguard the airway against infectious
agents by rapid deployment of their arsenals of inflammatory mediators.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Changes in airway physiology of wild-type and mast cell deficient mice in response to
OVA and MCh
(A) OVA challenge in sensitized mice (n=5) induced an immediate increase in RL that
gradually returned to baseline. Control animals (n=4) sensitized with OVA but challenged
with saline had no change in RL over baseline (*P<0.05 compared to OVA/saline). (B)
Increases in RL are dependent on mast cells, as there was no response in mast cell deficient
Wsh/Wsh mice (n=8) after antigen challenge (**P<0.001 compared to all other groups). (C)
IgE levels were comparable between wild-type (n=7) and mast cell deficient (n=7) mice
sensitized and challenged with OVA. (D) FOT measurement of airway mechanics after
antigen challenge. OVA challenge in sensitized mice (n=5) resulted in a significant increase
in Raw but no change in G compared to controls (n=4) (*P<0.05 compared to saline). (E)
Increases in Raw in sensitized mice are dependent on mast cells. Sensitized Wsh/Wsh mice
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(n=8) had no response to antigen challenge (**P<0.001 compared to all other groups). (F)
Aerosol methacholine (MCh) challenge in B6 mice (n=13) results in a dose dependent
increase in both Raw and G.
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Figure 2. Anaphylactic bronchoconstriction in wild-type and mast cell deficient mice with
allergic lung disease
(A) Allergic lung disease was induced by sensitization and repeated aerosol with OVA. B6
mice with inflamed airways (n=5) exhibited a significant increase in Raw after antigen
challenge but no change in G (*P<0.05 compared to saline). Saline challenged controls
(n=3) had no response. (B) Mast cell deficient Wsh/Wsh mice with an inflamed airway
(n=7) failed to respond to antigen challenge (**P<0.001 compared to all other groups). (C)
Histamine levels in B6 mice with inflamed airways were significantly increased after
antigen injection (n=6) compared to levels after saline injection (n=3) (**P<0.001 compared
to saline). Histamine was undetectable in Wsh/Wsh mice (n=7).
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Figure 3. Changes in airway physiology in response to serotonin and after inhibition of
serotonergic pathways
(A) Similar to antigen exposure, exogenous i.v. serotonin induces dose dependent increases
in Raw, but no change in G (n=13). (B) Vehicle treated mice (n=10) sensitized and
challenged with OVA had a significant increase in Raw. Pretreatment with PCPA (150 mg/
kg, n=15) abolished anaphylactic airway constriction in actively sensitized mice challenged
with OVA (**P<0.001 compared to all other groups). PCPA treatment had no effect on the
ability of mast cells to degranulate; histamine levels were the same in both groups of OVA
treated animals (n=10–15 per group). (C) PCPA treatment had no effect on the ability of the
airway smooth muscle to constrict to aerosolized MCh administered after antigen challenge
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(n=3). (D) PCPA treatment significantly attenuated plasma serotonin levels in OVA
challenged animals (n=4–6 per group) (*P<0.05 compared to all other groups). (E)
Passively sensitized serotonin transporter (5HTT)-deficient (n=4) and hererozygous mice
(n=5) challenged with DNP had a significant increase in Raw compared to controls (n=2 per
group). This response was similar to that of WT animals (n=5).
(*P<0.001; #P<0.001; §P<0.001). (F) Blockade of serotonin receptors with methiothepin (2
mg/kg, n=5) or ketanserin (12 mg/kg, n=5) abolished airway constriction after antigen
challenge in passively sensitized animals (**P<0.001 compared to all other groups).
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Figure 4. Anaphylactic bronchoconstriction following ablation of sensory C-fibers with capsaicin
(A) Sensory ablation with capsaicin (25–75 mg/kg) in adults (n=6) had no significant effect
on airway constriction after antigen challenge in passively sensitized mice
(*P<0.001, #P<0.01). (B) Degradation of C-fibers with capsaicin (50 mg/kg) in newborn
mice (n=7) had no effect on airway parameters after antigen challenge in passively
sensitized mice (*P<0.001, #P<0.001). (C) Antigen challenge in passively sensitized mice
(n=10) increased substance P content in the BAL. Neonatal treatment of capsaicin (n=5)
reduced BAL substance P after antigen challenge to levels seen in control animals (n=3)
(**P<0.05, compared to all other groups).
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Figure 5. Antigen-induced bronchoconstriction following cholinergic inhibition
(A) Blockade of cholinergic nAChRs with mecamylamine (4 mg/kg, n=8) abolished airway
constriction following antigen challenge in passively sensitized wild-type mice (**P<0.001
compared to all other groups). (B) Blockade of mAChRs with atropine (10 µM/kg, n=6)
resulted in complete loss of airway constriction after antigen challenge in passively
sensitized mice (**P<0.01 compared to all other groups). (C) In passively sensitized
animals, loss of the M3 receptor (n=6) resulted in abolishment of anaphylactic airway
constriction, whereas M1 receptor deficiency (n=6) resulted in a significant attenuation, but
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not complete loss of the response to antigen (*P<0.001, **P<0.01, #P<0.001, ##P<0.001,
§P<0.01).
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Figure 6. Vagotomy attenuates antigen and serotonin-induced changes in airway resistance
(A) Passively sensitized and challenged wild-type mice after dissection of the vagus nerve
(n=18) or a surgical sham (n=28). Antigen challenged mice showed a significant increase in
Raw that was abolished in vagotomized animals (**P <0.001 compared to all other groups).
(B) Histamine levels in the BAL fluid were measured after induction of passive anaphylaxis.
Vagotomy did not affect the levels of histamine in the BAL fluid (n=5 per group). (C)
Changes in Raw were abolished after vagotomy in OVA challenged sensitized mice (n=7–14
per group) with allergic lung disease (**P<0.001 compared to all other groups). (D)
Serotonin was delivered i.v. following either vagal dissection or pretreatment with atropine.
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Exogenous serotonin (n=11) resulted in a dose dependent increase in Raw that was sensitive
to both vagotomy (n=5) and atropine (n=6) (**P<0.01).
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Figure 7. Increased airway resistance in mice treated with non-provoking doses of both serotonin
and MCh
B6 mice exhibited increased sensitivity to serotonin when coupled with exposure to a non-
provoking dose of MCh. Low levels of either i.v. serotonin (0.075 pg, n=3) or aerosolized
MCh (6 mg/ml, n=3) does not result in a significant increase in Raw compared to saline
challenge. A significant increase in Raw was detected after non-provoking doses of serotonin
and MCh were delivered together (n=3) (**P<0.001 compared to all other groups).
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